The report "Gene Therapy Market By Vector Type (Adeno-associated Virus Vector, Lentiviral Vector, Herpes Virus Vector, Others), By Disease Type (Oncological, Disorders, Neurological Disorders, Rare Diseases, Others) - Global Forecasts to 2030" The global gene therapy market is projected to reach USD 8.9 billion in 2023, registering at a Compound Annual Growth Rate (CAGR) of 21.6% during the forecast period 2024-2030. The growth of the market is majorly driven by the increasing regulatory approvals for gene therapy products. Gene therapy is a medical approach that aims to treat or prevent disease by addressing the underlying genetic problem. Gene therapy treatments enable medical professionals to cure an issue by altering a person's genetic makeup rather than using medications or surgery. Gene therapy is being used to treat a small number of diseases, such as spinal muscular atrophy and Leber congenital amaurosis, which affect the muscles. Request sample report at https://www.precisionbusinessinsights.com/request-sample/?product_id=53824 Competitive Dashboard: The prominent key players operating in the global Gene Therapy market are Amgen Inc., AnGes, Inc., Novartis AG, Kite Pharma (a subsidiary of Gilead Sciences, Inc.), uniQure NV, Oxford Biomedica, Spark Therapeutics, Inc., SIBONO, bluebird bio, Inc., Shanghai Sunway Biotech Co. Ltd., Biogen, Dendreon Pharmaceuticals LLC., and Enzyvant Therapeutics GmbHAudubon Bioscience Regional Overview: The report also examines the current concerns and their Future Effects on the Gene Therapy Market by the region. The report covers all regions and countries, North America was the largest and Asia was the fastest-growing region in the Gene Therapy Market. The market has been segmented into numerous primary regions and a detailed evaluation of primary countries.
- North America (U.S., Canada)
- Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific)
- Latin America (Mexico, Brazil, Argentina, Columbia, Rest of Latin America)
- Middle East & Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa)
- The gene therapy market research report includes historical data, trending features, and market growth estimates for the future.
- The qualitative and quantitative analysis of the market along with CAGR calculation for the forecast period.
- The gene therapy market report helps to provide the best results for business enhancement and business growth.
- The report gives a comprehensive overview of both primary and secondary data.
- The gene therapy market key players covered here to help them strengthen their place in the market.